Revision of omalizumab dosing table for dosing every 4 instead of 2 weeks for specific ranges of bodyweight and baseline IgE
| Autor: | Lowe, Philip J., Georgiou, Panayiotis, Canvin, Janice |
|---|---|
| Zdroj: | In Regulatory Toxicology and Pharmacology February 2015 71(1):68-77 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect